Here, we aimed to characterize the effect of targeting aCDase on metabolic parameters in the CDAHFD model and in a second dietary model of NASH, the Fructose, Palmitate, and Cholesterol (FPC) model. This evidence concerns the gene ASAH1 and metabolic dysfunction-associated steatohepatitis.